These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. NEJM "failed its readers" by delay in publishing its concerns about VIGOR trial. Dobson R BMJ; 2006 Jul; 333(7559):116. PubMed ID: 16840463 [No Abstract] [Full Text] [Related]
43. Despite vow, drug makers still withhold data. Berenson A N Y Times Web; 2005 May; ():A1, C3. PubMed ID: 15952254 [No Abstract] [Full Text] [Related]
44. 94% of patients suing Merck over rofecoxib agree to company's offer. Charatan F BMJ; 2008 Mar; 336(7644):580-1. PubMed ID: 18340064 [No Abstract] [Full Text] [Related]
45. Rofecoxib, Merck, and the FDA. Kim PS; Reicin AS N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625342 [No Abstract] [Full Text] [Related]
47. Dispute over Vioxx study plays out in New England journal. Kondro W CMAJ; 2006 May; 174(10):1397. PubMed ID: 16682702 [No Abstract] [Full Text] [Related]
48. Profits, pressure, and perception: expensive research collides with medicine. Hoey J J Rheumatol; 2003 Aug; 30(8):1661-2. PubMed ID: 12913915 [No Abstract] [Full Text] [Related]
53. Medical journal apologizes for violating own standards. Altman LK N Y Times Web; 2000 Feb; ():A18. PubMed ID: 11873786 [No Abstract] [Full Text] [Related]
54. What's wrong with money in science. Stossel T; Shaywitz D Washington Post; 2006 Jul; ():B3. PubMed ID: 16838447 [No Abstract] [Full Text] [Related]
55. Correspondence (letter to the editor): Trend gives cause for concern. Maier C; Zenz M Dtsch Arztebl Int; 2010 Sep; 107(38):670-1; author reply 673-4. PubMed ID: 20953257 [No Abstract] [Full Text] [Related]
56. Merck Sharpe and Dohme versus Laporte. Laporte JR Lancet; 2004 Jul 31-Aug 6; 364(9432):416. PubMed ID: 15288737 [No Abstract] [Full Text] [Related]
58. Is drug research trustworthy? The pharmaceutical industry funnels money to prominent scientists who are doing research that affects its products--and nobody can stop it. Seife C Sci Am; 2012 Dec; 307(6):56-63. PubMed ID: 23230798 [No Abstract] [Full Text] [Related]
59. Clinical trials and tribulations. Allegations of waste: the 'seeding' study. Malakoff D Science; 2008 Oct; 322(5899):213. PubMed ID: 18845743 [No Abstract] [Full Text] [Related]
60. [Financial interests characterize published reports on coxiber. Whom can we rely on?]. Håkansson J Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]